The potential of food protein-derived anti-inflammatory peptides against various chronic inflammatory diseases

Journal of the Science of Food and Agriculture

Volumn 96, Issue 7, 2016, Pages 2303-2311

  Majumder, Kaustav ^a,b   Mine, Yoshinori ^b   Wu, Jianping ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF GUELPH   (Canada)

Author keywords

Atherosclerosis; Bioactive peptides; Chronic disease; Food protein; Inflammation; Insulin resistance; Obesity, anti inflammatory activity; Type 2 diabetes

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; PROTEIN;

CHEMISTRY; CHRONIC DISEASE; FOOD ANALYSIS; HUMAN; INFLAMMATION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHRONIC DISEASE; FOOD ANALYSIS; HUMANS; INFLAMMATION; PROTEINS;

EID: 84959449385     PISSN: 00225142     EISSN: 10970010     Source Type: Journal    
DOI: 10.1002/jsfa.7600     Document Type: Review

References (73)

1. Haslett C, Resolution of acute inflammation and the role of apoptosis in the tissue fate of granulocytes. Clin Sci 83:639-648 (1992).
2. Serhan CN and Savill J, Resolution of inflammation: the beginning programs the end. Nat Immunol 6:1191-1197 (2005).
3. Medzhitov R, Origin and physiological roles of inflammation. Nature 454:428-435 (2008).
4. Laveti D, Kumar M, Hemalatha R, Sistla R, Naidu VGM, Talla V et al., Anti-inflammatory treatments for chronic diseases: a review. Inflamm Allergy Drug Targets 12:349-361 (2013).
5. Scrivo R, Vasile M, Bartosiewicz I and Valesini G, Inflammation as 'common soil' of the multifactorial diseases. Autoimmun Rev 10:369-374 (2011).
6. Cohen ML, Changing patterns of infectious disease. Nature 406:762-767 (2000).
7. Mantovani A, Allavena P, Sica A and Balkwill F, Cancer-related inflammation. Nature 454:436-444 (2008).
8. Solomon DH, Karlson EW, Rimm EB, Cannuscio CC, Mandl LA, Manson JE et al., Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 107:1303-1307 (2003).
9. Balkwill F and Mantovani A, Inflammation and cancer: back to Virchow? Lancet 357:539-545 (2001).
10. Vendramini-Costa DB and Carvalho JE, Molecular link mechanisms between inflammation and cancer. Curr Pharmaceut Des 18:3831-3852 (2012).
11. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon III RO, Criqui M et al., Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107:499-511 (2003).
12. Hu FB, Meigs JB, Li TY, Rifai N and Manson JE, Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 53:693-700 (2004).
13. Minihane AM, Vinoy S, Russell WR, Baka A, Roche HM, Tuohy KM et al., Low-grade inflammation, diet composition and health: current research evidence and its translation. Br J Nutr 114:999-1012 (2015).
14. 2+ channels. J Agric Food Chem 63:6041-6050 (2015).
15. Nakai S and Alizadeh-Pasdar N, Rational designing of bioactive peptides, in Nutraceutical Proteins and Peptides in Health and Disease, ed. by Mine Y and Shahidi F. CRC Press, Boca Raton, FL, pp. 565-582 (2006).
16. Calder PC, Albers R, Antoine J-M, Blum S, Bourdet-Sicard R, Ferns GA et al., Inflammatory disease processes and interactions with nutrition. Br J Nutr 101(Suppl. 1):1-45 (2009).
17. Hartmann R and Meisel H, Food-derived peptides with biological activity: from research to food applications. Curr Opin Biotechnol 18:163-169 (2007).
18. Zhang H, Kovacs-Nolan J, Kodera T, Eto Y and Mine Y, γ-Glutamyl cysteine and γ-glutamyl valine inhibit TNF-α signaling in intestinal epithelial cells and reduce inflammation in a mouse model of colitis via allosteric activation of the calcium-sensing receptor. Biochim Biophys Acta Mol Basis Dis 1852:792-804 (2015).
19. Kovacs-Nolan J, Zhang H, Ibuki M, Nakamori T, Yoshiura K, Turner PV et al., The PepT1-transportable soy tripeptide VPY reduces intestinal inflammation. Biochim Biophys Acta Gen Subj 1820:1753-1763 (2012).
20. Nakamura T, Hirota T, Mizushima K, Ohki K, Naito Y, Yamamoto N et al., Milk-derived peptides, Val-Pro-Pro and Ile-Pro-Pro, attenuate atherosclerosis development in apolipoprotein E-deficient mice: a preliminary study. J Med Food 16:396-403 (2013).
21. Aihara K, Ishii H and Yoshida M, Casein-derived tripeptide, Val-Pro-Pro (VPP), modulates monocyte adhesion to vascular endothelium. J Atheroscler Thromb 16:594-603 (2009).
22. Huang W, Chakrabarti S, Majumder K, Jiang Y, Davidge ST and Wu J, Egg-derived peptide IRW inhibits TNF-α-induced inflammatory response and oxidative stress in endothelial cells. J Agric Food Chem 58:10840-10846 (2010).
23. Dunn RM and Wechsler ME, Anti-interleukin therapy in asthma. Clin Pharmacol Therapeut 97:55-65 (2015).
24. Kay AB, Allergy and allergic diseases. N Engl J Med 344:30-37 (2001).
25. Kicic A, Sutanto EN, Stevens PT, Knight DA and Stick SM, Intrinsic biochemical and functional differences in bronchial epithelial cells of children with asthma. Am J Respir Crit Care Med 174: 1110-1118 (2006).
26. Marini M, Vittori E, Hollemborg J and Mattoli S, Expression of the potent inflammatory cytokines, granulocyte-macrophage-colony-stimulating factor and interleukin-6 and interleukin-8, in bronchial epithelial cells of patients with asthma. J Allergy Clin Immunol 89:1001-1009 (1992).
27. Dienz O and Rincon M, The effects of IL-6 on CD4 T cell responses. Clin Immunol 130:27-33 (2009).
28. Coussens LM and Werb Z, Inflammation and cancer. Nature 420:860-867 (2002).
29. Rakoff-Nahoum S, Why cancer and inflammation? Yale J Biol Med 79:123-130 (2006).
30. Hanahan D and Weinberg RA, Hallmarks of cancer: the next generation. Cell 144:646-674 (2011).
31. Kroop IG and Shackman NH, Level of C-reactive protein as a measure of acute myocardial infarction. Proc Soc Exp Biol Med 86:95-97 (1954).
32. Anzai T, Yoshikawa T, Shiraki H, Asakura Y, Akaishi M, Mitamura H et al., C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction. Circulation 96:778-784 (1997).
33. Neutel JM and Smith DHG, Hypertension management: rationale for triple therapy based on mechanisms of action. Cardiovasc Therapeut 31:251-258 (2013).
34. Pickup JC, Chusney GD, Thomas SM and Burt D, Plasma interleukin-6, tumour necrosis factor α and blood cytokine production in type 2 diabetes. Life Sci 67:291-300 (2000).
35. Karalis KP, Giannogonas P, Kodela E, Koutmani Y, Zoumakis M and Teli T, Mechanisms of obesity and related pathology: linking immune responses to metabolic stress. FEBS J 276:5747-5754 (2009).
36. Suganami T, Nishida J and Ogawa Y, A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor α. Arterioscler Thromb Vasc Biol 25:2062-2068 (2005).
37. Cifuentes M, Fuentes C, Mattar P, Tobar N, Hugo E, Ben-Jonathan N et al., Obesity-associated proinflammatory cytokines increase calcium sensing receptor (CaSR) protein expression in primary human adipocytes and LS14 human adipose cell line. Arch Biochem Biophys 500:151-156 (2010).
38. Vachharajani V and Granger DN, Adipose tissue: a motor for the inflammation associated with obesity. IUBMB Life 61:424-430 (2009).
39. Wright NC, Looker AC, Saag KG, Curtis JR, Delzell ES, Randall S et al., The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine. J Bone Miner Res 29:2520-2526 (2014).
40. Mundy GR, Osteoporosis and inflammation. Nutr Rev 65(Suppl. s3):S147-S151 (2007).
41. Lacativa PGS and Farias MLF, Osteoporosis and inflammation. Arq Bras Endocrinol Metabol 54:123-132 (2010).
42. Sartor RB, Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol 3:390-407 (2006).
43. Plevy SE, Landers CJ, Prehn J, Carramanzana NM, Deem RL, Shealy D et al., A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease. J Immunol 159:6276-6282 (1997).
44. McGeer PL, Itagaki S, Boyes BE and McGeer EG, Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 38:1285-1291 (1988).
45. Tufekci KU, Meuwissen R, Genc S and Genc K. Inflammation in Parkinson's disease. Adv Protein Chem Struct Biol 88:69-132 (2012).
46. Hirsch EC and Hunot S, Neuroinflammation in Parkinson's disease: a target for neuroprotection? Lancet Neurol 8:382-397 (2009).
47. Herrera AJ, Castaño A, Venero JL, Cano J and Machado A, The single intranigral injection of LPS as a new model for studying the selective effects of inflammatory reactions on dopaminergic system. Neurobiol Dis 7:429-447 (2000).
48. Murray PJ, The primary mechanism of the IL-10-regulated antiinflammatory response is to selectively inhibit transcription. Proc Natl Acad Sci USA 102:8686-8691 (2005).
49. Sarkar P and Kumar S, Tissue specific role of calcium sensing receptor. Atlas Genet Cytogenet Oncol Haematol 18:532-539 (2014).
50. Tak PP and Firestein GS, NF-κB: a key role in inflammatory diseases. J Clin Invest 107:7-11 (2001).
51. Chen CC, Rosenbloom CL, Anderson DC and Manning AM, Selective inhibition of E-selectin, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 expression by inhibitors of I kappa B-alpha phosphorylation. J Immunol 155:3538-3545 (1995).
52. Kyriakis JM and Avruch J, Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update. Physiol Rev 92:689-737 (2012).
53. Kim EK and Choi EJ, Pathological roles of MAPK signaling pathways in human diseases. Biochim Biophys Acta Mol Basis Dis 1802:396-405 (2010).
54. Schaeffer HJ and Weber MJ, Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol Cell Biol 19:2435-2444 (1999).
55. Hirai S, Horii S, Matsuzaki Y, Ono S, Shimmura Y, Sato K et al., Anti-inflammatory effect of pyroglutamyl-leucine on lipopolysaccharide-stimulated RAW 264.7 macrophages. Life Sci 117:1-6 (2014).
56. Herlaar E and Brown Z, p38 MAPK signalling cascades in inflammatory disease. Mol Med Today 5:439-447 (1999).
57. Kaplan MH, STAT signaling in inflammation. JAK-STAT 2:e24198 (2013).
58. Murray PJ, The JAK-STAT signaling pathway: input and output integration. J Immunol 178:2623-2629 (2007).
59. Mizumachi K and Kurisaki J, Milk proteins, in Nutraceutical Proteins and Peptides in Health and Disease, ed. by Mine Y and Shahidi F. CRC Press, Boca Raton, FL, pp. 431-444 (2006).
60. Majumder K, Chakrabarti S, Davidge ST and Wu J, Structure and activity study of egg protein ovotransferrin derived peptides (IRW and IQW) on endothelial inflammatory response and oxidative stress. J Agric Food Chem 61:2120-2129 (2013).
61. Majumder K, Chakrabarti S, Morton JS, Panahi S, Kaufman S, Davidge ST et al., Egg-derived tri-peptide IRW exerts antihypertensive effects in spontaneously hypertensive rats. PLoS ONE 8:e82829 (2013).
62. Malinowski J, Klempt M, Clawin-Rädecker I, Lorenzen PC and Meisel H. Identification of a NFκB inhibitory peptide from tryptic β-casein hydrolysate. Food Chem 165:129-133 (2014).
63. Hsieh C-C, Hernández-Ledesma B and de Lumen BO, Soybean peptide lunasin suppresses in vitro and in vivo 7, 12-dimethylbenz[a]anthracene-induced tumorigenesis. J Food Sci 75:H311-H316 (2010).
64. 1 integrin and suppresses FAK/ERK/NF-κB signaling. Cancer Lett 313:167-180 (2011).
65. Yang X, Zhu J, Tung C-Y, Gardiner G, Wang Q, Chang H-C et al., Lunasin alleviates allergic airway inflammation while increases antigen-specific Tregs. PloS ONE 10:e0115330 (2015).
66. Ortega-González M, Capitán-Cañadas F, Requena P, Ocón B, Romero-Calvo I, Aranda C et al., Validation of bovine glycomacropeptide as an intestinal anti-inflammatory nutraceutical in the lymphocyte-transfer model of colitis. Br J Nutr 111:1202-1212 (2014).
67. Nishiuchi H, Suehiro M, Sugimoto R and Yamagishi K, Preparation of a γ-glutamylcysteine-enriched yeast extract from a newly developed GSH2-deficient strain. J Biosci Bioeng 115:50-54 (2013).
68. Dunkel A, Köster J and Hofmann T, Molecular and sensory characterization of γ-glutamyl peptides as key contributors to the kokumi taste of edible beans (Phaseolus vulgaris L.). J Agric Food Chem 55:6712-6719 (2007).
69. Wada S, Sato K, Ohta R, Wada E, Bou Y, Fujiwara M et al., Ingestion of low dose pyroglutamyl leucine improves dextran sulfate sodium-induced colitis and intestinal microbiota in mice. J Agric Food Chem 61:8807-8813 (2013).
70. Sato K, Egashira Y, Ono S, Mochizuki S, Shimmura Y, Suzuki Y et al., Identification of a hepatoprotective peptide in wheat gluten hydrolysate against d-galactosamine-induced acute hepatitis in rats. J Agric Food Chem 61:6304-6310 (2013).
71. Broadhead GK, Mun H, Avlani VA, Jourdon O, Church WB, Christopoulos A et al., Allosteric modulation of the calcium-sensing receptor by γ-glutamyl peptides: inhibition of PTH secretion, suppression of intracellular cAMP levels, and a common mechanism of action with l-amino acids. J Biol Chem 286:8786-8797 (2011).
72. Suzuki Y, Asano M, Sato K, Asami M, Sakamoto A, Tsutsumi M et al., Wheat gluten hydrolysate alters the progress of hepatic pathology induced by prolonged carbon tetrachloride administration in rat. Biomed Res 22:481-488 (2012).
73. Yan D, Chen D, Shen J, Xiao G, van Wijnen AJ and Im H-J, Bovine lactoferricin is anti-inflammatory and anti-catabolic in human articular cartilage and synovium. J Cell Physiol 228:447-456 (2013).